Questcor®

For assistance with any problem or issue, please contact customer service at 1.800.411.3065 (M-F from 8:00 a.m. to 4:00 p.m. Pacific Standard Time.)

In the event of an emergency, please contact us 24 hours a day, 7 days a week at 1.800.411.3065

Working for a small company like Questcor allows you the opportunity to express and implement your own unique ideas. The company encourages professional growth without boundaries.

-Christine T.
Acthar Specialist

Questcor's working environment has allowed me to be successful by offering an excellent management team, realistic attainable goals, and a competitive compensation plan.

-Doug D.
Regional Manager

Hard work, teamwork, and a can-do spirit personify the people and the culture at Questcor.

-Todd B.
Acthar Specialist

Working at Questcor has been a rewarding growth opportunity both personally and professionally. Over the years and through many changes in the company, it has been a great experience to work with so many talented people who are focused on improving the lives of patients suffering from CNS and inflammatory disorders.

-Heather B.
Market Research

This is a place where your ideas and opinions not only matter, but are encouraged. Truly unique, like no other company you will work for, a company with a very bright future.

-Matthew D.
Regional Manager

For me working at Questcor has been great. The company culture is excellent; I have a diversity of responsibilities, and most importantly I have very good work/life balance.

-Temi O.
Finance and Accounting

Mission/Business Strategy

Corporate Mission

At Questcor, we are a biopharmaceutical company focused on providing prescription drugs for the treatment of rare central nervous system and inflammatory disorders, and by doing this successfully we will build long term value for our shareholders. Our efforts are currently focused on the fields of neurology and nephrology, areas of medicine which have significant unmet medical needs.

Our Business Strategy

Our highly experienced Sales and Marketing teams are presently focused on increasing the usage of our primary marketed product, H.P Acthar® Gel, among specialists who treat patients with multiple sclerosis. In addition, our Medical Affairs personnel are working with leading researchers to explore promising additional uses for this important product in a variety of other conditions.